In alignment with its global expansion strategy and mission to provide innovative healthcare solutions across the MENA region, DEVARTLab proudly announces a new strategic distribution partnership with AD Ports Group—one of the most prominent and trusted logistics and supply chain enablers in the UAE.
This new partnership will allow DEVARTLab to introduce Exotropin, a specialized and highly sought-after solution for growth hormone deficiencies, to healthcare providers and patients across the United Arab Emirates.
With AD Ports Group's unmatched
logistical network and healthcare distribution infrastructure, DEVARTLab is
confident this collaboration will ensure widespread access to Exotropin with
the highest standards of efficiency, safety, and service.
This alliance reflects both companies' shared vision for delivering next-generation therapies and advanced healthcare services to the region.
DEVARTLab expresses its
appreciation for AD Ports Group's leadership, innovation, and excellence in
healthcare logistics.
AD Ports Group is more than just
a logistics giant — it's a catalyst for progress and a key strategic partner in
reshaping the future of regional healthcare accessibility.